← All trials
NCT05433350
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2022
- Primary completion
- Jun 30, 2024
- Completion date
- Jun 30, 2024
- First posted
- Jun 27, 2022
- Last posted
- Aug 19, 2022
- Enrollment
- 35
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Drugs for Neglected Diseases InitiativeLead sponsor
- Government of the Democratic Republic of the CongoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.